These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4406296)

  • 21. [Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
    Nocke-Finck L; Breuer H; Reimers D
    Dtsch Med Wochenschr; 1973 Aug; 98(33):1521-3. PubMed ID: 4580141
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antagonistic action of rifampicin and isoniazid on the metabolism of oral contraceptives].
    Bessot JC; Vandevenne A; Petitjean R; Burghard G
    Nouv Presse Med; 1977 Apr; 6(18):1568. PubMed ID: 866147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter: Oral contraceptive failure due to drug interaction.
    Dommisse J
    S Afr Med J; 1976 May; 50(21):796. PubMed ID: 935957
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 25. Rifampicin: an immunosuppressant?
    Nilsson BS
    Lancet; 1971 Aug; 2(7720):374. PubMed ID: 4105069
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.
    Kisa O; Albay A; Bedir O; Baylan O; Doganci L
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):284-8. PubMed ID: 12661845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifampin--a major new chemotherapeutic agent for the treatment of tuberculosis.
    Daniel TM
    N Engl J Med; 1969 Mar; 280(11):615-6. PubMed ID: 4974534
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifampin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):151-4. PubMed ID: 18486058
    [No Abstract]   [Full Text] [Related]  

  • 29. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
    Liu Y; Cui J; Wang R; Wang X; Drlica K; Zhao X
    J Antimicrob Chemother; 2005 Dec; 56(6):1172-5. PubMed ID: 16207765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Our experience with Rifampicin].
    Kramer R; Simon K
    Prax Pneumol; 1971 Oct; 25(10):610-4. PubMed ID: 5137081
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs].
    Daddi G; Lucchesi M; Mancini P
    Ann Ist Carlo Forlanini; 1969; 29(1):35-40. PubMed ID: 5405839
    [No Abstract]   [Full Text] [Related]  

  • 33. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs].
    Nitti V; Ninni A
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):871-95. PubMed ID: 5304754
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of rifampicin on experimental tuberculosis].
    Uvarova OA; Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1976 Jan; (l):65-70. PubMed ID: 995913
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antituberculous activity of rifampicin for the experimental tuberculosis of guinea pigs].
    Toyoara M
    Kekkaku; 1970 Nov; 45(11):375-8. PubMed ID: 5484188
    [No Abstract]   [Full Text] [Related]  

  • 36. Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment.
    Cassano R; Trombino S; Ferrarelli T; Mauro MV; Giraldi C; Manconi M; Fadda AM; Picci N
    J Biomed Mater Res A; 2012 Feb; 100(2):536-42. PubMed ID: 22162280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of rifampicin therapy on oral anticoagulation with acenocoumarol].
    Beran G
    Prax Pneumol; 1972 Jun; 26(6):350-3. PubMed ID: 5047490
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rifampicin].
    Tousek J
    Cas Lek Cesk; 1971 Jul; 110(31):742-3. PubMed ID: 5564717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.